HM013 5 mg Pill - red & white capsule/oblong, 19mm
Generic Name: fruquintinib
Pill with imprint HM013 5 mg is Red & White, Capsule/Oblong and has been identified as Fruzaqla 5 mg. It is supplied by Takeda Pharmaceutical Company Limited.
Fruzaqla is used in the treatment of Colorectal Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. Fruzaqla 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for HM013 5 mg
Fruzaqla
- Generic Name
- fruquintinib
- Imprint
- HM013 5 mg
- Strength
- 5 mg
- Color
- Red & White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceutical Company Limited
- National Drug Code (NDC)
- 63020-0225
More about Fruzaqla (fruquintinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
